amlodipine has been researched along with Hyperlipoproteinemia Type II in 2 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).
Excerpt | Relevance | Reference |
---|---|---|
"Amlodipine inhibited AngII-induced aortic aneurysms in both the abdominal and ascending regions, and atherosclerosis in hypercholesterolemic mice." | 7.79 | Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. ( Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL, 2013) |
"Amlodipine inhibited AngII-induced aortic aneurysms in both the abdominal and ascending regions, and atherosclerosis in hypercholesterolemic mice." | 3.79 | Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. ( Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamamoto, H | 1 |
Takada, T | 1 |
Yamanashi, Y | 1 |
Ogura, M | 1 |
Masuo, Y | 1 |
Harada-Shiba, M | 1 |
Suzuki, H | 1 |
Chen, X | 1 |
Rateri, DL | 1 |
Howatt, DA | 1 |
Balakrishnan, A | 1 |
Moorleghen, JJ | 1 |
Morris, AJ | 1 |
Charnigo, R | 1 |
Cassis, LA | 1 |
Daugherty, A | 1 |
2 other studies available for amlodipine and Hyperlipoproteinemia Type II
Article | Year |
---|---|
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body.
Topics: Amlodipine; Animals; Biological Transport; Cholesterol; Drug Carriers; Hyperlipoproteinemia Type II; | 2017 |
Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.
Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Hyperlipoproteinemia Type II; | 2013 |